英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
sortes查看　sortes　在百度字典中的解释百度英翻中〔查看〕
sortes查看　sortes　在Google字典中的解释Google英翻中〔查看〕
sortes查看　sortes　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Financials and Filings - Viatris
    Viatris releases financial and regulatory documents to the public, including earnings information and filings to the United States Securities and Exchange Commission (SEC) Download these documents below Data provided by Kaleidoscope
  • Document Library - Viatris
    In no event shall Viatris or any of its affiliates, directors, employees, officers, consultants and service providers be liable for, directly or indirectly, any damages or any kind or nature, including without limitation, direct, indirect, incidental, consequential, or any claims or losses, whether foreseeable or not; or whether the user has
  • Investor Relations - Viatris
    Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions Viatris to Participate in Upcoming Investor Conferences
  • Investor Relations | Viatris
    Investor Relations | Viatris
  • Global Policy Issue Brief - viatris. com
    For example, Viatris leveraged the 505(b)(2) pathway to reformulate a treatment for patients with chronic obstructive pulmonary disease (COPD) from a dry powder inhaler to a nebulizer improving ease of use for patients while
  • Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
    First quarter 2025 total revenues were $3 3 billion, down 11% on a reported basis and down 2% on a divestiture-adjusted operational basis compared to first quarter 2024, primarily driven by the negative Indore Impact Excluding the Indore Impact, total revenues would have increased 2% on a divestiture-adjusted operational basis compared to
  • Viatris Q4 and Full Year 2024 Earnings Presentation
    expect full year 2025 new product revenues of $450-$550 million; key anticipated 2025 launches of iron sucrose, ocreotide and glucagon; advancing 11 phase 3 programs and expect 6 dta readouts in 2025; anticipated milestones; selatogrel and cenerimod phase 3
  • Document Library - Viatris
    At Viatris, we empower people worldwide to live healthier at every stage of life
  • Building Sustainable Access at Scale - viatris. com. tr
    Viatris supports the U N Sustainable Development Goals (SDGs) The 17 SDGs launched in 2015 serve as a roadmap for a more sustainable and inclusive development
  • Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 . . .
    PITTSBURGH, May 8, 2025 PRNewswire -- Viatris Inc (Nasdaq: VTRS), a global healthcare company, today announced positive results from its Phase 3 program of the novel fast-acting formulation of meloxicam (MR-107A-02) for the treatment of moderate-to-severe acute pain





中文字典-英文字典  2005-2009